Medical Care
Global Nuclear Medicine Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
- Mar 27, 25
- ID: 159618
- Pages: 97
- Figures: 100
- Views: 49
The global Nuclear Medicine market size was US$ 6875 million in 2024 and is forecast to a readjusted size of US$ 11090 million by 2031 with a CAGR of 7.4% during the forecast period 2025-2031.
Nuclear Medicine，or Radiopharmaceuticals， are radioactive compounds administered to the patient, and monitored via specific imaging devices, for diagnosis and therapeutic purposes. It is composed of a radioisotope bond to an organic molecule. The organic molecule conveys the radioisotope to specific organs, tissues or cells. The radioisotope is selected for its properties. Radiopharmaceuticals are used in the field of nuclear medicine as radioactive tracers in medical imaging and in therapy for many diseases (for example, brachytherapy). Many radiopharmaceuticals use technetium-99m (Tc-99m) which has many useful properties as a gamma-emitting tracer nuclide.
Market Drivers
The nuclear medicine market is experiencing significant growth due to the increasing prevalence of chronic diseases, including cancer, cardiovascular diseases, and neurological disorders, which require advanced diagnostic and therapeutic solutions. Nuclear medicine provides highly targeted treatment, such as radioisotope therapy, and is crucial for precise imaging techniques like PET and SPECT, which offer better disease detection and management. Advances in radiopharmaceuticals, such as the development of new radioisotopes, and the rising demand for personalized medicine further fuel the market's expansion. Additionally, the growing emphasis on early diagnosis and treatment monitoring in healthcare systems, along with the availability of funding for research and development in nuclear medicine, contributes to market growth.
Market Challenges
Despite its advantages, the nuclear medicine market faces challenges related to the high costs of nuclear medicine treatments and imaging technologies. The infrastructure required for nuclear medicine, including specialized facilities, trained professionals, and the availability of radiopharmaceuticals, can be prohibitively expensive, especially in developing regions. Additionally, concerns over the safe handling and disposal of radioactive materials, regulatory hurdles, and the relatively short half-life of certain isotopes create logistical difficulties in terms of production, distribution, and patient access. These challenges can limit the widespread adoption of nuclear medicine, particularly in low-resource healthcare settings.
The global Nuclear Medicine market is strategically segmented by company, region (country), by Type, and by Application. This report empowers stakeholders to capitalize on emerging opportunities, optimize product strategies, and outperform competitors through data-driven insights on revenue and forecasts across regions, by Type, and by Application for 2020-2031.
Market Segmentation
By Company:
Cardinal Health
GE Healthcare
Jubilant Pharma
Novartis
Curium Pharma
SIEMENS
Lantheus
Bracco Imaging
Bayer
Eli Lilly
Aurobindo Pharma
Mundipharma
China Isotope & Radiation
Yantai Dongcheng
By Type: (Dominant Segment vs High-Margin Innovation)
Diagnostic Nuclear Medicine
Therapeutic Nuclear Medicine
By Application: (Core Demand Driver vs Emerging Opportunity)
Oncology
Thyroid
Cardiology
Others
By Region
Macro-Regional Analysis: Market Size & Growth Forecasts
- North America
- Europe
- Asia-Pacific
- South America
- Middle East & Africa
Micro-Local Market Deep Dive: Strategic Insights
- Competitive Landscape: Player dominance vs. disruptors (e.g., Cardinal Health in Europe)
- Emerging Product Trends: Diagnostic Nuclear Medicine adoption vs. Therapeutic Nuclear Medicine premiumization
- Demand-Side Dynamics: Oncology growth in China vs. Thyroid potential in North America
- Localized Consumer Needs: Regulatory hurdles in EU vs. price sensitivity in India
Focus Markets:
North America
Europe
China
Japan
Chapter Outline
Chapter 1: Report scope, executive summary, and market evolution scenarios (short/mid/long term).
Chapter 2: Quantitative analysis of Nuclear Medicine market size and growth potential at global, regional, and country levels.
Chapter 3: Competitive benchmarking of manufacturers (revenue, market share, M&A, R&D focus).
Chapter 4: Type-based segmentation analysis – Uncovering blue ocean markets (e.g., Therapeutic Nuclear Medicine in China).
Chapter 5: Application-based segmentation analysis – High-growth downstream opportunities (e.g., Thyroid in India).
Chapter 6: Regional revenue breakdown by company, type, application and customer.
Chapter 7: Key manufacturer profiles – Financials, product portfolios, and strategic developments.
Chapter 8: Market dynamics – Drivers, restraints, regulatory impacts, and risk mitigation strategies.
Chapter 9: Actionable conclusions and strategic recommendations.
Why This Report?
Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Nuclear Medicine value chain, addressing:
- Market entry risks/opportunities by region
- Product mix optimization based on local practices
- Competitor tactics in fragmented vs. consolidated markets
Nuclear Medicine，or Radiopharmaceuticals， are radioactive compounds administered to the patient, and monitored via specific imaging devices, for diagnosis and therapeutic purposes. It is composed of a radioisotope bond to an organic molecule. The organic molecule conveys the radioisotope to specific organs, tissues or cells. The radioisotope is selected for its properties. Radiopharmaceuticals are used in the field of nuclear medicine as radioactive tracers in medical imaging and in therapy for many diseases (for example, brachytherapy). Many radiopharmaceuticals use technetium-99m (Tc-99m) which has many useful properties as a gamma-emitting tracer nuclide.
Market Drivers
The nuclear medicine market is experiencing significant growth due to the increasing prevalence of chronic diseases, including cancer, cardiovascular diseases, and neurological disorders, which require advanced diagnostic and therapeutic solutions. Nuclear medicine provides highly targeted treatment, such as radioisotope therapy, and is crucial for precise imaging techniques like PET and SPECT, which offer better disease detection and management. Advances in radiopharmaceuticals, such as the development of new radioisotopes, and the rising demand for personalized medicine further fuel the market's expansion. Additionally, the growing emphasis on early diagnosis and treatment monitoring in healthcare systems, along with the availability of funding for research and development in nuclear medicine, contributes to market growth.
Market Challenges
Despite its advantages, the nuclear medicine market faces challenges related to the high costs of nuclear medicine treatments and imaging technologies. The infrastructure required for nuclear medicine, including specialized facilities, trained professionals, and the availability of radiopharmaceuticals, can be prohibitively expensive, especially in developing regions. Additionally, concerns over the safe handling and disposal of radioactive materials, regulatory hurdles, and the relatively short half-life of certain isotopes create logistical difficulties in terms of production, distribution, and patient access. These challenges can limit the widespread adoption of nuclear medicine, particularly in low-resource healthcare settings.
The global Nuclear Medicine market is strategically segmented by company, region (country), by Type, and by Application. This report empowers stakeholders to capitalize on emerging opportunities, optimize product strategies, and outperform competitors through data-driven insights on revenue and forecasts across regions, by Type, and by Application for 2020-2031.
Market Segmentation
By Company:
Cardinal Health
GE Healthcare
Jubilant Pharma
Novartis
Curium Pharma
SIEMENS
Lantheus
Bracco Imaging
Bayer
Eli Lilly
Aurobindo Pharma
Mundipharma
China Isotope & Radiation
Yantai Dongcheng
By Type: (Dominant Segment vs High-Margin Innovation)
Diagnostic Nuclear Medicine
Therapeutic Nuclear Medicine
By Application: (Core Demand Driver vs Emerging Opportunity)
Oncology
Thyroid
Cardiology
Others
By Region
Macro-Regional Analysis: Market Size & Growth Forecasts
- North America
- Europe
- Asia-Pacific
- South America
- Middle East & Africa
Micro-Local Market Deep Dive: Strategic Insights
- Competitive Landscape: Player dominance vs. disruptors (e.g., Cardinal Health in Europe)
- Emerging Product Trends: Diagnostic Nuclear Medicine adoption vs. Therapeutic Nuclear Medicine premiumization
- Demand-Side Dynamics: Oncology growth in China vs. Thyroid potential in North America
- Localized Consumer Needs: Regulatory hurdles in EU vs. price sensitivity in India
Focus Markets:
North America
Europe
China
Japan
Chapter Outline
Chapter 1: Report scope, executive summary, and market evolution scenarios (short/mid/long term).
Chapter 2: Quantitative analysis of Nuclear Medicine market size and growth potential at global, regional, and country levels.
Chapter 3: Competitive benchmarking of manufacturers (revenue, market share, M&A, R&D focus).
Chapter 4: Type-based segmentation analysis – Uncovering blue ocean markets (e.g., Therapeutic Nuclear Medicine in China).
Chapter 5: Application-based segmentation analysis – High-growth downstream opportunities (e.g., Thyroid in India).
Chapter 6: Regional revenue breakdown by company, type, application and customer.
Chapter 7: Key manufacturer profiles – Financials, product portfolios, and strategic developments.
Chapter 8: Market dynamics – Drivers, restraints, regulatory impacts, and risk mitigation strategies.
Chapter 9: Actionable conclusions and strategic recommendations.
Why This Report?
Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Nuclear Medicine value chain, addressing:
- Market entry risks/opportunities by region
- Product mix optimization based on local practices
- Competitor tactics in fragmented vs. consolidated markets
1 Report Overview
1.1 Study Scope
1.2 Market by Type
1.2.1 Global Market Size Growth by Type: 2020 VS 2024 VS 2031
1.2.2 Diagnostic Nuclear Medicine
1.2.3 Therapeutic Nuclear Medicine
1.3 Market by Application
1.3.1 Global Market Share by Application: 2020 VS 2024 VS 2031
1.3.2 Oncology
1.3.3 Thyroid
1.3.4 Cardiology
1.3.5 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Nuclear Medicine Market Perspective (2020-2031)
2.2 Global Market Size by Region: 2020 VS 2024 VS 2031
2.3 Global Nuclear Medicine Revenue Market Share by Region (2020-2025)
2.4 Global Nuclear Medicine Revenue Forecast by Region (2026-2031)
2.5 Major Region and Emerging Market Analysis
2.5.1 North America Nuclear Medicine Market Size and Prospective (2020-2031)
2.5.2 Europe Nuclear Medicine Market Size and Prospective (2020-2031)
2.5.3 China Nuclear Medicine Market Size and Prospective (2020-2031)
2.5.4 Japan Nuclear Medicine Market Size and Prospective (2020-2031)
3 Breakdown Data by Type
3.1 Global Nuclear Medicine Historic Market Size by Type (2020-2025)
3.2 Global Nuclear Medicine Forecasted Market Size by Type (2026-2031)
3.3 Different Types Nuclear Medicine Representative Players
4 Breakdown Data by Application
4.1 Global Nuclear Medicine Historic Market Size by Application (2020-2025)
4.2 Global Nuclear Medicine Forecasted Market Size by Application (2026-2031)
4.3 New Sources of Growth in Nuclear Medicine Application
5 Competition Landscape by Players
5.1 Global Top Players by Revenue
5.1.1 Global Top Nuclear Medicine Players by Revenue (2020-2025)
5.1.2 Global Nuclear Medicine Revenue Market Share by Players (2020-2025)
5.2 Global Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
5.3 Players Covered: Ranking by Nuclear Medicine Revenue
5.4 Global Nuclear Medicine Market Concentration Analysis
5.4.1 Global Nuclear Medicine Market Concentration Ratio (CR5 and HHI)
5.4.2 Global Top 10 and Top 5 Companies by Nuclear Medicine Revenue in 2024
5.5 Global Key Players of Nuclear Medicine Head office and Area Served
5.6 Global Key Players of Nuclear Medicine, Product and Application
5.7 Global Key Players of Nuclear Medicine, Date of Enter into This Industry
5.8 Mergers & Acquisitions, Expansion Plans
6 Region Analysis
6.1 North America Market: Players, Segments and Downstream
6.1.1 North America Nuclear Medicine Revenue by Company (2020-2025)
6.1.2 North America Market Size by Type
6.1.2.1 North America Nuclear Medicine Market Size by Type (2020-2025)
6.1.2.2 North America Nuclear Medicine Market Share by Type (2020-2025)
6.1.3 North America Market Size by Application
6.1.3.1 North America Nuclear Medicine Market Size by Application (2020-2025)
6.1.3.2 North America Nuclear Medicine Market Share by Application (2020-2025)
6.1.4 North America Market Trend and Opportunities
6.2 Europe Market: Players, Segments and Downstream
6.2.1 Europe Nuclear Medicine Revenue by Company (2020-2025)
6.2.2 Europe Market Size by Type
6.2.2.1 Europe Nuclear Medicine Market Size by Type (2020-2025)
6.2.2.2 Europe Nuclear Medicine Market Share by Type (2020-2025)
6.2.3 Europe Market Size by Application
6.2.3.1 Europe Nuclear Medicine Market Size by Application (2020-2025)
6.2.3.2 Europe Nuclear Medicine Market Share by Application (2020-2025)
6.2.4 Europe Market Trend and Opportunities
6.3 China Market: Players, Segments and Downstream
6.3.1 China Nuclear Medicine Revenue by Company (2020-2025)
6.3.2 China Market Size by Type
6.3.2.1 China Nuclear Medicine Market Size by Type (2020-2025)
6.3.2.2 China Nuclear Medicine Market Share by Type (2020-2025)
6.3.3 China Market Size by Application
6.3.3.1 China Nuclear Medicine Market Size by Application (2020-2025)
6.3.3.2 China Nuclear Medicine Market Share by Application (2020-2025)
6.3.4 China Market Trend and Opportunities
6.4 Japan Market: Players, Segments and Downstream
6.4.1 Japan Nuclear Medicine Revenue by Company (2020-2025)
6.4.2 Japan Market Size by Type
6.4.2.1 Japan Nuclear Medicine Market Size by Type (2020-2025)
6.4.2.2 Japan Nuclear Medicine Market Share by Type (2020-2025)
6.4.3 Japan Market Size by Application
6.4.3.1 Japan Nuclear Medicine Market Size by Application (2020-2025)
6.4.3.2 Japan Nuclear Medicine Market Share by Application (2020-2025)
6.4.4 Japan Market Trend and Opportunities
7 Key Players Profiles
7.1 Cardinal Health
7.1.1 Cardinal Health Company Details
7.1.2 Cardinal Health Business Overview
7.1.3 Cardinal Health Nuclear Medicine Introduction
7.1.4 Cardinal Health Revenue in Nuclear Medicine Business (2020-2025)
7.1.5 Cardinal Health Recent Development
7.2 GE Healthcare
7.2.1 GE Healthcare Company Details
7.2.2 GE Healthcare Business Overview
7.2.3 GE Healthcare Nuclear Medicine Introduction
7.2.4 GE Healthcare Revenue in Nuclear Medicine Business (2020-2025)
7.2.5 GE Healthcare Recent Development
7.3 Jubilant Pharma
7.3.1 Jubilant Pharma Company Details
7.3.2 Jubilant Pharma Business Overview
7.3.3 Jubilant Pharma Nuclear Medicine Introduction
7.3.4 Jubilant Pharma Revenue in Nuclear Medicine Business (2020-2025)
7.3.5 Jubilant Pharma Recent Development
7.4 Novartis
7.4.1 Novartis Company Details
7.4.2 Novartis Business Overview
7.4.3 Novartis Nuclear Medicine Introduction
7.4.4 Novartis Revenue in Nuclear Medicine Business (2020-2025)
7.4.5 Novartis Recent Development
7.5 Curium Pharma
7.5.1 Curium Pharma Company Details
7.5.2 Curium Pharma Business Overview
7.5.3 Curium Pharma Nuclear Medicine Introduction
7.5.4 Curium Pharma Revenue in Nuclear Medicine Business (2020-2025)
7.5.5 Curium Pharma Recent Development
7.6 SIEMENS
7.6.1 SIEMENS Company Details
7.6.2 SIEMENS Business Overview
7.6.3 SIEMENS Nuclear Medicine Introduction
7.6.4 SIEMENS Revenue in Nuclear Medicine Business (2020-2025)
7.6.5 SIEMENS Recent Development
7.7 Lantheus
7.7.1 Lantheus Company Details
7.7.2 Lantheus Business Overview
7.7.3 Lantheus Nuclear Medicine Introduction
7.7.4 Lantheus Revenue in Nuclear Medicine Business (2020-2025)
7.7.5 Lantheus Recent Development
7.8 Bracco Imaging
7.8.1 Bracco Imaging Company Details
7.8.2 Bracco Imaging Business Overview
7.8.3 Bracco Imaging Nuclear Medicine Introduction
7.8.4 Bracco Imaging Revenue in Nuclear Medicine Business (2020-2025)
7.8.5 Bracco Imaging Recent Development
7.9 Bayer
7.9.1 Bayer Company Details
7.9.2 Bayer Business Overview
7.9.3 Bayer Nuclear Medicine Introduction
7.9.4 Bayer Revenue in Nuclear Medicine Business (2020-2025)
7.9.5 Bayer Recent Development
7.10 Eli Lilly
7.10.1 Eli Lilly Company Details
7.10.2 Eli Lilly Business Overview
7.10.3 Eli Lilly Nuclear Medicine Introduction
7.10.4 Eli Lilly Revenue in Nuclear Medicine Business (2020-2025)
7.10.5 Eli Lilly Recent Development
7.11 Aurobindo Pharma
7.11.1 Aurobindo Pharma Company Details
7.11.2 Aurobindo Pharma Business Overview
7.11.3 Aurobindo Pharma Nuclear Medicine Introduction
7.11.4 Aurobindo Pharma Revenue in Nuclear Medicine Business (2020-2025)
7.11.5 Aurobindo Pharma Recent Development
7.12 Mundipharma
7.12.1 Mundipharma Company Details
7.12.2 Mundipharma Business Overview
7.12.3 Mundipharma Nuclear Medicine Introduction
7.12.4 Mundipharma Revenue in Nuclear Medicine Business (2020-2025)
7.12.5 Mundipharma Recent Development
7.13 China Isotope & Radiation
7.13.1 China Isotope & Radiation Company Details
7.13.2 China Isotope & Radiation Business Overview
7.13.3 China Isotope & Radiation Nuclear Medicine Introduction
7.13.4 China Isotope & Radiation Revenue in Nuclear Medicine Business (2020-2025)
7.13.5 China Isotope & Radiation Recent Development
7.14 Yantai Dongcheng
7.14.1 Yantai Dongcheng Company Details
7.14.2 Yantai Dongcheng Business Overview
7.14.3 Yantai Dongcheng Nuclear Medicine Introduction
7.14.4 Yantai Dongcheng Revenue in Nuclear Medicine Business (2020-2025)
7.14.5 Yantai Dongcheng Recent Development
8 Nuclear Medicine Market Dynamics
8.1 Nuclear Medicine Industry Trends
8.2 Nuclear Medicine Market Drivers
8.3 Nuclear Medicine Market Challenges
8.4 Nuclear Medicine Market Restraints
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.1.1 Research Programs/Design
10.1.1.2 Market Size Estimation
10.1.1.3 Market Breakdown and Data Triangulation
10.1.2 Data Source
10.1.2.1 Secondary Sources
10.1.2.2 Primary Sources
10.2 Author Details
10.3 Disclaimer
1.1 Study Scope
1.2 Market by Type
1.2.1 Global Market Size Growth by Type: 2020 VS 2024 VS 2031
1.2.2 Diagnostic Nuclear Medicine
1.2.3 Therapeutic Nuclear Medicine
1.3 Market by Application
1.3.1 Global Market Share by Application: 2020 VS 2024 VS 2031
1.3.2 Oncology
1.3.3 Thyroid
1.3.4 Cardiology
1.3.5 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Nuclear Medicine Market Perspective (2020-2031)
2.2 Global Market Size by Region: 2020 VS 2024 VS 2031
2.3 Global Nuclear Medicine Revenue Market Share by Region (2020-2025)
2.4 Global Nuclear Medicine Revenue Forecast by Region (2026-2031)
2.5 Major Region and Emerging Market Analysis
2.5.1 North America Nuclear Medicine Market Size and Prospective (2020-2031)
2.5.2 Europe Nuclear Medicine Market Size and Prospective (2020-2031)
2.5.3 China Nuclear Medicine Market Size and Prospective (2020-2031)
2.5.4 Japan Nuclear Medicine Market Size and Prospective (2020-2031)
3 Breakdown Data by Type
3.1 Global Nuclear Medicine Historic Market Size by Type (2020-2025)
3.2 Global Nuclear Medicine Forecasted Market Size by Type (2026-2031)
3.3 Different Types Nuclear Medicine Representative Players
4 Breakdown Data by Application
4.1 Global Nuclear Medicine Historic Market Size by Application (2020-2025)
4.2 Global Nuclear Medicine Forecasted Market Size by Application (2026-2031)
4.3 New Sources of Growth in Nuclear Medicine Application
5 Competition Landscape by Players
5.1 Global Top Players by Revenue
5.1.1 Global Top Nuclear Medicine Players by Revenue (2020-2025)
5.1.2 Global Nuclear Medicine Revenue Market Share by Players (2020-2025)
5.2 Global Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
5.3 Players Covered: Ranking by Nuclear Medicine Revenue
5.4 Global Nuclear Medicine Market Concentration Analysis
5.4.1 Global Nuclear Medicine Market Concentration Ratio (CR5 and HHI)
5.4.2 Global Top 10 and Top 5 Companies by Nuclear Medicine Revenue in 2024
5.5 Global Key Players of Nuclear Medicine Head office and Area Served
5.6 Global Key Players of Nuclear Medicine, Product and Application
5.7 Global Key Players of Nuclear Medicine, Date of Enter into This Industry
5.8 Mergers & Acquisitions, Expansion Plans
6 Region Analysis
6.1 North America Market: Players, Segments and Downstream
6.1.1 North America Nuclear Medicine Revenue by Company (2020-2025)
6.1.2 North America Market Size by Type
6.1.2.1 North America Nuclear Medicine Market Size by Type (2020-2025)
6.1.2.2 North America Nuclear Medicine Market Share by Type (2020-2025)
6.1.3 North America Market Size by Application
6.1.3.1 North America Nuclear Medicine Market Size by Application (2020-2025)
6.1.3.2 North America Nuclear Medicine Market Share by Application (2020-2025)
6.1.4 North America Market Trend and Opportunities
6.2 Europe Market: Players, Segments and Downstream
6.2.1 Europe Nuclear Medicine Revenue by Company (2020-2025)
6.2.2 Europe Market Size by Type
6.2.2.1 Europe Nuclear Medicine Market Size by Type (2020-2025)
6.2.2.2 Europe Nuclear Medicine Market Share by Type (2020-2025)
6.2.3 Europe Market Size by Application
6.2.3.1 Europe Nuclear Medicine Market Size by Application (2020-2025)
6.2.3.2 Europe Nuclear Medicine Market Share by Application (2020-2025)
6.2.4 Europe Market Trend and Opportunities
6.3 China Market: Players, Segments and Downstream
6.3.1 China Nuclear Medicine Revenue by Company (2020-2025)
6.3.2 China Market Size by Type
6.3.2.1 China Nuclear Medicine Market Size by Type (2020-2025)
6.3.2.2 China Nuclear Medicine Market Share by Type (2020-2025)
6.3.3 China Market Size by Application
6.3.3.1 China Nuclear Medicine Market Size by Application (2020-2025)
6.3.3.2 China Nuclear Medicine Market Share by Application (2020-2025)
6.3.4 China Market Trend and Opportunities
6.4 Japan Market: Players, Segments and Downstream
6.4.1 Japan Nuclear Medicine Revenue by Company (2020-2025)
6.4.2 Japan Market Size by Type
6.4.2.1 Japan Nuclear Medicine Market Size by Type (2020-2025)
6.4.2.2 Japan Nuclear Medicine Market Share by Type (2020-2025)
6.4.3 Japan Market Size by Application
6.4.3.1 Japan Nuclear Medicine Market Size by Application (2020-2025)
6.4.3.2 Japan Nuclear Medicine Market Share by Application (2020-2025)
6.4.4 Japan Market Trend and Opportunities
7 Key Players Profiles
7.1 Cardinal Health
7.1.1 Cardinal Health Company Details
7.1.2 Cardinal Health Business Overview
7.1.3 Cardinal Health Nuclear Medicine Introduction
7.1.4 Cardinal Health Revenue in Nuclear Medicine Business (2020-2025)
7.1.5 Cardinal Health Recent Development
7.2 GE Healthcare
7.2.1 GE Healthcare Company Details
7.2.2 GE Healthcare Business Overview
7.2.3 GE Healthcare Nuclear Medicine Introduction
7.2.4 GE Healthcare Revenue in Nuclear Medicine Business (2020-2025)
7.2.5 GE Healthcare Recent Development
7.3 Jubilant Pharma
7.3.1 Jubilant Pharma Company Details
7.3.2 Jubilant Pharma Business Overview
7.3.3 Jubilant Pharma Nuclear Medicine Introduction
7.3.4 Jubilant Pharma Revenue in Nuclear Medicine Business (2020-2025)
7.3.5 Jubilant Pharma Recent Development
7.4 Novartis
7.4.1 Novartis Company Details
7.4.2 Novartis Business Overview
7.4.3 Novartis Nuclear Medicine Introduction
7.4.4 Novartis Revenue in Nuclear Medicine Business (2020-2025)
7.4.5 Novartis Recent Development
7.5 Curium Pharma
7.5.1 Curium Pharma Company Details
7.5.2 Curium Pharma Business Overview
7.5.3 Curium Pharma Nuclear Medicine Introduction
7.5.4 Curium Pharma Revenue in Nuclear Medicine Business (2020-2025)
7.5.5 Curium Pharma Recent Development
7.6 SIEMENS
7.6.1 SIEMENS Company Details
7.6.2 SIEMENS Business Overview
7.6.3 SIEMENS Nuclear Medicine Introduction
7.6.4 SIEMENS Revenue in Nuclear Medicine Business (2020-2025)
7.6.5 SIEMENS Recent Development
7.7 Lantheus
7.7.1 Lantheus Company Details
7.7.2 Lantheus Business Overview
7.7.3 Lantheus Nuclear Medicine Introduction
7.7.4 Lantheus Revenue in Nuclear Medicine Business (2020-2025)
7.7.5 Lantheus Recent Development
7.8 Bracco Imaging
7.8.1 Bracco Imaging Company Details
7.8.2 Bracco Imaging Business Overview
7.8.3 Bracco Imaging Nuclear Medicine Introduction
7.8.4 Bracco Imaging Revenue in Nuclear Medicine Business (2020-2025)
7.8.5 Bracco Imaging Recent Development
7.9 Bayer
7.9.1 Bayer Company Details
7.9.2 Bayer Business Overview
7.9.3 Bayer Nuclear Medicine Introduction
7.9.4 Bayer Revenue in Nuclear Medicine Business (2020-2025)
7.9.5 Bayer Recent Development
7.10 Eli Lilly
7.10.1 Eli Lilly Company Details
7.10.2 Eli Lilly Business Overview
7.10.3 Eli Lilly Nuclear Medicine Introduction
7.10.4 Eli Lilly Revenue in Nuclear Medicine Business (2020-2025)
7.10.5 Eli Lilly Recent Development
7.11 Aurobindo Pharma
7.11.1 Aurobindo Pharma Company Details
7.11.2 Aurobindo Pharma Business Overview
7.11.3 Aurobindo Pharma Nuclear Medicine Introduction
7.11.4 Aurobindo Pharma Revenue in Nuclear Medicine Business (2020-2025)
7.11.5 Aurobindo Pharma Recent Development
7.12 Mundipharma
7.12.1 Mundipharma Company Details
7.12.2 Mundipharma Business Overview
7.12.3 Mundipharma Nuclear Medicine Introduction
7.12.4 Mundipharma Revenue in Nuclear Medicine Business (2020-2025)
7.12.5 Mundipharma Recent Development
7.13 China Isotope & Radiation
7.13.1 China Isotope & Radiation Company Details
7.13.2 China Isotope & Radiation Business Overview
7.13.3 China Isotope & Radiation Nuclear Medicine Introduction
7.13.4 China Isotope & Radiation Revenue in Nuclear Medicine Business (2020-2025)
7.13.5 China Isotope & Radiation Recent Development
7.14 Yantai Dongcheng
7.14.1 Yantai Dongcheng Company Details
7.14.2 Yantai Dongcheng Business Overview
7.14.3 Yantai Dongcheng Nuclear Medicine Introduction
7.14.4 Yantai Dongcheng Revenue in Nuclear Medicine Business (2020-2025)
7.14.5 Yantai Dongcheng Recent Development
8 Nuclear Medicine Market Dynamics
8.1 Nuclear Medicine Industry Trends
8.2 Nuclear Medicine Market Drivers
8.3 Nuclear Medicine Market Challenges
8.4 Nuclear Medicine Market Restraints
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.1.1 Research Programs/Design
10.1.1.2 Market Size Estimation
10.1.1.3 Market Breakdown and Data Triangulation
10.1.2 Data Source
10.1.2.1 Secondary Sources
10.1.2.2 Primary Sources
10.2 Author Details
10.3 Disclaimer
List of Tables
Table 1. Global Nuclear Medicine Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
Table 2. Global Nuclear Medicine Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
Table 3. Global Market Nuclear Medicine Market Size (US$ Million) by Region:2020 VS 2024 VS 2031
Table 4. Global Nuclear Medicine Revenue (US$ Million) Market Share by Region (2020-2025)
Table 5. Global Nuclear Medicine Revenue Share by Region (2020-2025)
Table 6. Global Nuclear Medicine Revenue (US$ Million) Forecast by Region (2026-2031)
Table 7. Global Nuclear Medicine Revenue Share Forecast by Region (2026-2031)
Table 8. Global Nuclear Medicine Market Size by Type (2020-2025) & (US$ Million)
Table 9. Global Nuclear Medicine Revenue Market Share by Type (2020-2025)
Table 10. Global Nuclear Medicine Forecasted Market Size by Type (2026-2031) & (US$ Million)
Table 11. Global Nuclear Medicine Revenue Market Share by Type (2026-2031)
Table 12. Representative Players of Each Type
Table 13. Global Nuclear Medicine Market Size by Application (2020-2025) & (US$ Million)
Table 14. Global Nuclear Medicine Revenue Market Share by Application (2020-2025)
Table 15. Global Nuclear Medicine Forecasted Market Size by Application (2026-2031) & (US$ Million)
Table 16. Global Nuclear Medicine Revenue Market Share by Application (2026-2031)
Table 17. New Sources of Growth in Nuclear Medicine Application
Table 18. Global Nuclear Medicine Revenue by Players (2020-2025) & (US$ Million)
Table 19. Global Nuclear Medicine Market Share by Players (2020-2025)
Table 20. Global Top Nuclear Medicine Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Nuclear Medicine as of 2024)
Table 21. Ranking of Global Top Nuclear Medicine Companies by Revenue (US$ Million) in 2024
Table 22. Global 5 Largest Players Market Share by Nuclear Medicine Revenue (CR5 and HHI) & (2020-2025)
Table 23. Global Key Players of Nuclear Medicine, Headquarters and Area Served
Table 24. Global Key Players of Nuclear Medicine, Product and Application
Table 25. Global Key Players of Nuclear Medicine, Date of Enter into This Industry
Table 26. Mergers & Acquisitions, Expansion Plans
Table 27. North America Nuclear Medicine Revenue by Company (2020-2025) & (US$ Million)
Table 28. North America Nuclear Medicine Revenue Market Share by Company (2020-2025)
Table 29. North America Nuclear Medicine Market Size by Type (2020-2025) & (US$ Million)
Table 30. North America Nuclear Medicine Market Size by Application (2020-2025) & (US$ Million)
Table 31. Europe Nuclear Medicine Revenue by Company (2020-2025) & (US$ Million)
Table 32. Europe Nuclear Medicine Revenue Market Share by Company (2020-2025)
Table 33. Europe Nuclear Medicine Market Size by Type (2020-2025) & (US$ Million)
Table 34. Europe Nuclear Medicine Market Size by Application (2020-2025) & (US$ Million)
Table 35. China Nuclear Medicine Revenue by Company (2020-2025) & (US$ Million)
Table 36. China Nuclear Medicine Revenue Market Share by Company (2020-2025)
Table 37. China Nuclear Medicine Market Size by Type (2020-2025) & (US$ Million)
Table 38. China Nuclear Medicine Market Size by Application (2020-2025) & (US$ Million)
Table 39. Japan Nuclear Medicine Revenue by Company (2020-2025) & (US$ Million)
Table 40. Japan Nuclear Medicine Revenue Market Share by Company (2020-2025)
Table 41. Japan Nuclear Medicine Market Size by Type (2020-2025) & (US$ Million)
Table 42. Japan Nuclear Medicine Market Size by Application (2020-2025) & (US$ Million)
Table 43. Cardinal Health Company Details
Table 44. Cardinal Health Business Overview
Table 45. Cardinal Health Nuclear Medicine Product
Table 46. Cardinal Health Revenue in Nuclear Medicine Business (2020-2025) & (US$ Million)
Table 47. Cardinal Health Recent Development
Table 48. GE Healthcare Company Details
Table 49. GE Healthcare Business Overview
Table 50. GE Healthcare Nuclear Medicine Product
Table 51. GE Healthcare Revenue in Nuclear Medicine Business (2020-2025) & (US$ Million)
Table 52. GE Healthcare Recent Development
Table 53. Jubilant Pharma Company Details
Table 54. Jubilant Pharma Business Overview
Table 55. Jubilant Pharma Nuclear Medicine Product
Table 56. Jubilant Pharma Revenue in Nuclear Medicine Business (2020-2025) & (US$ Million)
Table 57. Jubilant Pharma Recent Development
Table 58. Novartis Company Details
Table 59. Novartis Business Overview
Table 60. Novartis Nuclear Medicine Product
Table 61. Novartis Revenue in Nuclear Medicine Business (2020-2025) & (US$ Million)
Table 62. Novartis Recent Development
Table 63. Curium Pharma Company Details
Table 64. Curium Pharma Business Overview
Table 65. Curium Pharma Nuclear Medicine Product
Table 66. Curium Pharma Revenue in Nuclear Medicine Business (2020-2025) & (US$ Million)
Table 67. Curium Pharma Recent Development
Table 68. SIEMENS Company Details
Table 69. SIEMENS Business Overview
Table 70. SIEMENS Nuclear Medicine Product
Table 71. SIEMENS Revenue in Nuclear Medicine Business (2020-2025) & (US$ Million)
Table 72. SIEMENS Recent Development
Table 73. Lantheus Company Details
Table 74. Lantheus Business Overview
Table 75. Lantheus Nuclear Medicine Product
Table 76. Lantheus Revenue in Nuclear Medicine Business (2020-2025) & (US$ Million)
Table 77. Lantheus Recent Development
Table 78. Bracco Imaging Company Details
Table 79. Bracco Imaging Business Overview
Table 80. Bracco Imaging Nuclear Medicine Product
Table 81. Bracco Imaging Revenue in Nuclear Medicine Business (2020-2025) & (US$ Million)
Table 82. Bracco Imaging Recent Development
Table 83. Bayer Company Details
Table 84. Bayer Business Overview
Table 85. Bayer Nuclear Medicine Product
Table 86. Bayer Revenue in Nuclear Medicine Business (2020-2025) & (US$ Million)
Table 87. Bayer Recent Development
Table 88. Eli Lilly Company Details
Table 89. Eli Lilly Business Overview
Table 90. Eli Lilly Nuclear Medicine Product
Table 91. Eli Lilly Revenue in Nuclear Medicine Business (2020-2025) & (US$ Million)
Table 92. Eli Lilly Recent Development
Table 93. Aurobindo Pharma Company Details
Table 94. Aurobindo Pharma Business Overview
Table 95. Aurobindo Pharma Nuclear Medicine Product
Table 96. Aurobindo Pharma Revenue in Nuclear Medicine Business (2020-2025) & (US$ Million)
Table 97. Aurobindo Pharma Recent Development
Table 98. Mundipharma Company Details
Table 99. Mundipharma Business Overview
Table 100. Mundipharma Nuclear Medicine Product
Table 101. Mundipharma Revenue in Nuclear Medicine Business (2020-2025) & (US$ Million)
Table 102. Mundipharma Recent Development
Table 103. China Isotope & Radiation Company Details
Table 104. China Isotope & Radiation Business Overview
Table 105. China Isotope & Radiation Nuclear Medicine Product
Table 106. China Isotope & Radiation Revenue in Nuclear Medicine Business (2020-2025) & (US$ Million)
Table 107. China Isotope & Radiation Recent Development
Table 108. Yantai Dongcheng Company Details
Table 109. Yantai Dongcheng Business Overview
Table 110. Yantai Dongcheng Nuclear Medicine Product
Table 111. Yantai Dongcheng Revenue in Nuclear Medicine Business (2020-2025) & (US$ Million)
Table 112. Yantai Dongcheng Recent Development
Table 113. Nuclear Medicine Market Trends
Table 114. Nuclear Medicine Market Drivers
Table 115. Nuclear Medicine Market Challenges
Table 116. Nuclear Medicine Market Restraints
Table 117. Research Programs/Design for This Report
Table 118. Key Data Information from Secondary Sources
Table 119. Key Data Information from Primary Sources
List of Figures
Figure 1. Nuclear Medicine Product Picture
Figure 2. Global Nuclear Medicine Market Share by Type: 2024 VS 2031
Figure 3. Diagnostic Nuclear Medicine Features
Figure 4. Therapeutic Nuclear Medicine Features
Figure 5. Global Nuclear Medicine Market Share by Application: 2024 VS 2031
Figure 6. Oncology
Figure 7. Thyroid
Figure 8. Cardiology
Figure 9. Others
Figure 10. Nuclear Medicine Report Years Considered
Figure 11. Global Nuclear Medicine Market Size (US$ Million), Year-over-Year: 2020-2031
Figure 12. Global Nuclear Medicine Market Size, (US$ Million), 2020 VS 2024 VS 2031
Figure 13. Global Nuclear Medicine Revenue Market Share by Region: 2020 VS 2024
Figure 14. North America Nuclear Medicine Revenue (US$ Million) Growth Rate (2020-2031)
Figure 15. Europe Nuclear Medicine Revenue (US$ Million) Growth Rate (2020-2031)
Figure 16. China Nuclear Medicine Revenue (US$ Million) Growth Rate (2020-2031)
Figure 17. Japan Nuclear Medicine Revenue (US$ Million) Growth Rate (2020-2031)
Figure 18. Global Nuclear Medicine Market Share by Players in 2024
Figure 19. Global Top Nuclear Medicine Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Nuclear Medicine as of 2024)
Figure 20. The Top 10 and 5 Players Market Share by Nuclear Medicine Revenue in 2024
Figure 21. North America Nuclear Medicine Market Share by Type (2020-2025)
Figure 22. North America Nuclear Medicine Market Share by Application (2020-2025)
Figure 23. Europe Nuclear Medicine Market Share by Type (2020-2025)
Figure 24. Europe Nuclear Medicine Market Share by Application (2020-2025)
Figure 25. China Nuclear Medicine Market Share by Type (2020-2025)
Figure 26. China Nuclear Medicine Market Share by Application (2020-2025)
Figure 27. Japan Nuclear Medicine Market Share by Type (2020-2025)
Figure 28. Japan Nuclear Medicine Market Share by Application (2020-2025)
Figure 29. Cardinal Health Revenue Growth Rate in Nuclear Medicine Business (2020-2025)
Figure 30. GE Healthcare Revenue Growth Rate in Nuclear Medicine Business (2020-2025)
Figure 31. Jubilant Pharma Revenue Growth Rate in Nuclear Medicine Business (2020-2025)
Figure 32. Novartis Revenue Growth Rate in Nuclear Medicine Business (2020-2025)
Figure 33. Curium Pharma Revenue Growth Rate in Nuclear Medicine Business (2020-2025)
Figure 34. SIEMENS Revenue Growth Rate in Nuclear Medicine Business (2020-2025)
Figure 35. Lantheus Revenue Growth Rate in Nuclear Medicine Business (2020-2025)
Figure 36. Bracco Imaging Revenue Growth Rate in Nuclear Medicine Business (2020-2025)
Figure 37. Bayer Revenue Growth Rate in Nuclear Medicine Business (2020-2025)
Figure 38. Eli Lilly Revenue Growth Rate in Nuclear Medicine Business (2020-2025)
Figure 39. Aurobindo Pharma Revenue Growth Rate in Nuclear Medicine Business (2020-2025)
Figure 40. Mundipharma Revenue Growth Rate in Nuclear Medicine Business (2020-2025)
Figure 41. China Isotope & Radiation Revenue Growth Rate in Nuclear Medicine Business (2020-2025)
Figure 42. Yantai Dongcheng Revenue Growth Rate in Nuclear Medicine Business (2020-2025)
Figure 43. Bottom-up and Top-down Approaches for This Report
Figure 44. Data Triangulation
Figure 45. Key Executives Interviewed
Table 1. Global Nuclear Medicine Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
Table 2. Global Nuclear Medicine Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
Table 3. Global Market Nuclear Medicine Market Size (US$ Million) by Region:2020 VS 2024 VS 2031
Table 4. Global Nuclear Medicine Revenue (US$ Million) Market Share by Region (2020-2025)
Table 5. Global Nuclear Medicine Revenue Share by Region (2020-2025)
Table 6. Global Nuclear Medicine Revenue (US$ Million) Forecast by Region (2026-2031)
Table 7. Global Nuclear Medicine Revenue Share Forecast by Region (2026-2031)
Table 8. Global Nuclear Medicine Market Size by Type (2020-2025) & (US$ Million)
Table 9. Global Nuclear Medicine Revenue Market Share by Type (2020-2025)
Table 10. Global Nuclear Medicine Forecasted Market Size by Type (2026-2031) & (US$ Million)
Table 11. Global Nuclear Medicine Revenue Market Share by Type (2026-2031)
Table 12. Representative Players of Each Type
Table 13. Global Nuclear Medicine Market Size by Application (2020-2025) & (US$ Million)
Table 14. Global Nuclear Medicine Revenue Market Share by Application (2020-2025)
Table 15. Global Nuclear Medicine Forecasted Market Size by Application (2026-2031) & (US$ Million)
Table 16. Global Nuclear Medicine Revenue Market Share by Application (2026-2031)
Table 17. New Sources of Growth in Nuclear Medicine Application
Table 18. Global Nuclear Medicine Revenue by Players (2020-2025) & (US$ Million)
Table 19. Global Nuclear Medicine Market Share by Players (2020-2025)
Table 20. Global Top Nuclear Medicine Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Nuclear Medicine as of 2024)
Table 21. Ranking of Global Top Nuclear Medicine Companies by Revenue (US$ Million) in 2024
Table 22. Global 5 Largest Players Market Share by Nuclear Medicine Revenue (CR5 and HHI) & (2020-2025)
Table 23. Global Key Players of Nuclear Medicine, Headquarters and Area Served
Table 24. Global Key Players of Nuclear Medicine, Product and Application
Table 25. Global Key Players of Nuclear Medicine, Date of Enter into This Industry
Table 26. Mergers & Acquisitions, Expansion Plans
Table 27. North America Nuclear Medicine Revenue by Company (2020-2025) & (US$ Million)
Table 28. North America Nuclear Medicine Revenue Market Share by Company (2020-2025)
Table 29. North America Nuclear Medicine Market Size by Type (2020-2025) & (US$ Million)
Table 30. North America Nuclear Medicine Market Size by Application (2020-2025) & (US$ Million)
Table 31. Europe Nuclear Medicine Revenue by Company (2020-2025) & (US$ Million)
Table 32. Europe Nuclear Medicine Revenue Market Share by Company (2020-2025)
Table 33. Europe Nuclear Medicine Market Size by Type (2020-2025) & (US$ Million)
Table 34. Europe Nuclear Medicine Market Size by Application (2020-2025) & (US$ Million)
Table 35. China Nuclear Medicine Revenue by Company (2020-2025) & (US$ Million)
Table 36. China Nuclear Medicine Revenue Market Share by Company (2020-2025)
Table 37. China Nuclear Medicine Market Size by Type (2020-2025) & (US$ Million)
Table 38. China Nuclear Medicine Market Size by Application (2020-2025) & (US$ Million)
Table 39. Japan Nuclear Medicine Revenue by Company (2020-2025) & (US$ Million)
Table 40. Japan Nuclear Medicine Revenue Market Share by Company (2020-2025)
Table 41. Japan Nuclear Medicine Market Size by Type (2020-2025) & (US$ Million)
Table 42. Japan Nuclear Medicine Market Size by Application (2020-2025) & (US$ Million)
Table 43. Cardinal Health Company Details
Table 44. Cardinal Health Business Overview
Table 45. Cardinal Health Nuclear Medicine Product
Table 46. Cardinal Health Revenue in Nuclear Medicine Business (2020-2025) & (US$ Million)
Table 47. Cardinal Health Recent Development
Table 48. GE Healthcare Company Details
Table 49. GE Healthcare Business Overview
Table 50. GE Healthcare Nuclear Medicine Product
Table 51. GE Healthcare Revenue in Nuclear Medicine Business (2020-2025) & (US$ Million)
Table 52. GE Healthcare Recent Development
Table 53. Jubilant Pharma Company Details
Table 54. Jubilant Pharma Business Overview
Table 55. Jubilant Pharma Nuclear Medicine Product
Table 56. Jubilant Pharma Revenue in Nuclear Medicine Business (2020-2025) & (US$ Million)
Table 57. Jubilant Pharma Recent Development
Table 58. Novartis Company Details
Table 59. Novartis Business Overview
Table 60. Novartis Nuclear Medicine Product
Table 61. Novartis Revenue in Nuclear Medicine Business (2020-2025) & (US$ Million)
Table 62. Novartis Recent Development
Table 63. Curium Pharma Company Details
Table 64. Curium Pharma Business Overview
Table 65. Curium Pharma Nuclear Medicine Product
Table 66. Curium Pharma Revenue in Nuclear Medicine Business (2020-2025) & (US$ Million)
Table 67. Curium Pharma Recent Development
Table 68. SIEMENS Company Details
Table 69. SIEMENS Business Overview
Table 70. SIEMENS Nuclear Medicine Product
Table 71. SIEMENS Revenue in Nuclear Medicine Business (2020-2025) & (US$ Million)
Table 72. SIEMENS Recent Development
Table 73. Lantheus Company Details
Table 74. Lantheus Business Overview
Table 75. Lantheus Nuclear Medicine Product
Table 76. Lantheus Revenue in Nuclear Medicine Business (2020-2025) & (US$ Million)
Table 77. Lantheus Recent Development
Table 78. Bracco Imaging Company Details
Table 79. Bracco Imaging Business Overview
Table 80. Bracco Imaging Nuclear Medicine Product
Table 81. Bracco Imaging Revenue in Nuclear Medicine Business (2020-2025) & (US$ Million)
Table 82. Bracco Imaging Recent Development
Table 83. Bayer Company Details
Table 84. Bayer Business Overview
Table 85. Bayer Nuclear Medicine Product
Table 86. Bayer Revenue in Nuclear Medicine Business (2020-2025) & (US$ Million)
Table 87. Bayer Recent Development
Table 88. Eli Lilly Company Details
Table 89. Eli Lilly Business Overview
Table 90. Eli Lilly Nuclear Medicine Product
Table 91. Eli Lilly Revenue in Nuclear Medicine Business (2020-2025) & (US$ Million)
Table 92. Eli Lilly Recent Development
Table 93. Aurobindo Pharma Company Details
Table 94. Aurobindo Pharma Business Overview
Table 95. Aurobindo Pharma Nuclear Medicine Product
Table 96. Aurobindo Pharma Revenue in Nuclear Medicine Business (2020-2025) & (US$ Million)
Table 97. Aurobindo Pharma Recent Development
Table 98. Mundipharma Company Details
Table 99. Mundipharma Business Overview
Table 100. Mundipharma Nuclear Medicine Product
Table 101. Mundipharma Revenue in Nuclear Medicine Business (2020-2025) & (US$ Million)
Table 102. Mundipharma Recent Development
Table 103. China Isotope & Radiation Company Details
Table 104. China Isotope & Radiation Business Overview
Table 105. China Isotope & Radiation Nuclear Medicine Product
Table 106. China Isotope & Radiation Revenue in Nuclear Medicine Business (2020-2025) & (US$ Million)
Table 107. China Isotope & Radiation Recent Development
Table 108. Yantai Dongcheng Company Details
Table 109. Yantai Dongcheng Business Overview
Table 110. Yantai Dongcheng Nuclear Medicine Product
Table 111. Yantai Dongcheng Revenue in Nuclear Medicine Business (2020-2025) & (US$ Million)
Table 112. Yantai Dongcheng Recent Development
Table 113. Nuclear Medicine Market Trends
Table 114. Nuclear Medicine Market Drivers
Table 115. Nuclear Medicine Market Challenges
Table 116. Nuclear Medicine Market Restraints
Table 117. Research Programs/Design for This Report
Table 118. Key Data Information from Secondary Sources
Table 119. Key Data Information from Primary Sources
List of Figures
Figure 1. Nuclear Medicine Product Picture
Figure 2. Global Nuclear Medicine Market Share by Type: 2024 VS 2031
Figure 3. Diagnostic Nuclear Medicine Features
Figure 4. Therapeutic Nuclear Medicine Features
Figure 5. Global Nuclear Medicine Market Share by Application: 2024 VS 2031
Figure 6. Oncology
Figure 7. Thyroid
Figure 8. Cardiology
Figure 9. Others
Figure 10. Nuclear Medicine Report Years Considered
Figure 11. Global Nuclear Medicine Market Size (US$ Million), Year-over-Year: 2020-2031
Figure 12. Global Nuclear Medicine Market Size, (US$ Million), 2020 VS 2024 VS 2031
Figure 13. Global Nuclear Medicine Revenue Market Share by Region: 2020 VS 2024
Figure 14. North America Nuclear Medicine Revenue (US$ Million) Growth Rate (2020-2031)
Figure 15. Europe Nuclear Medicine Revenue (US$ Million) Growth Rate (2020-2031)
Figure 16. China Nuclear Medicine Revenue (US$ Million) Growth Rate (2020-2031)
Figure 17. Japan Nuclear Medicine Revenue (US$ Million) Growth Rate (2020-2031)
Figure 18. Global Nuclear Medicine Market Share by Players in 2024
Figure 19. Global Top Nuclear Medicine Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Nuclear Medicine as of 2024)
Figure 20. The Top 10 and 5 Players Market Share by Nuclear Medicine Revenue in 2024
Figure 21. North America Nuclear Medicine Market Share by Type (2020-2025)
Figure 22. North America Nuclear Medicine Market Share by Application (2020-2025)
Figure 23. Europe Nuclear Medicine Market Share by Type (2020-2025)
Figure 24. Europe Nuclear Medicine Market Share by Application (2020-2025)
Figure 25. China Nuclear Medicine Market Share by Type (2020-2025)
Figure 26. China Nuclear Medicine Market Share by Application (2020-2025)
Figure 27. Japan Nuclear Medicine Market Share by Type (2020-2025)
Figure 28. Japan Nuclear Medicine Market Share by Application (2020-2025)
Figure 29. Cardinal Health Revenue Growth Rate in Nuclear Medicine Business (2020-2025)
Figure 30. GE Healthcare Revenue Growth Rate in Nuclear Medicine Business (2020-2025)
Figure 31. Jubilant Pharma Revenue Growth Rate in Nuclear Medicine Business (2020-2025)
Figure 32. Novartis Revenue Growth Rate in Nuclear Medicine Business (2020-2025)
Figure 33. Curium Pharma Revenue Growth Rate in Nuclear Medicine Business (2020-2025)
Figure 34. SIEMENS Revenue Growth Rate in Nuclear Medicine Business (2020-2025)
Figure 35. Lantheus Revenue Growth Rate in Nuclear Medicine Business (2020-2025)
Figure 36. Bracco Imaging Revenue Growth Rate in Nuclear Medicine Business (2020-2025)
Figure 37. Bayer Revenue Growth Rate in Nuclear Medicine Business (2020-2025)
Figure 38. Eli Lilly Revenue Growth Rate in Nuclear Medicine Business (2020-2025)
Figure 39. Aurobindo Pharma Revenue Growth Rate in Nuclear Medicine Business (2020-2025)
Figure 40. Mundipharma Revenue Growth Rate in Nuclear Medicine Business (2020-2025)
Figure 41. China Isotope & Radiation Revenue Growth Rate in Nuclear Medicine Business (2020-2025)
Figure 42. Yantai Dongcheng Revenue Growth Rate in Nuclear Medicine Business (2020-2025)
Figure 43. Bottom-up and Top-down Approaches for This Report
Figure 44. Data Triangulation
Figure 45. Key Executives Interviewed
Our team would be happy to assist you with your queries.
About us
Accurate data, The latest market trends, And deeper research directions.
Our sole purpose is to provide a basis for leaders in all walks of life to make more appropriate decisions, to help companies solve existing problems and achieve business goals
Latest reports
Global Oral Antianginal Drugs Market Outlook, In‑Depth Analysis & Forecast to 2031
Oct 21, 25
Global Polyester BCF Yarns Market Outlook, In‑Depth Analysis & Forecast to 2031
Oct 21, 25
Global Glass Mat Reinforced Thermoplastics (GMT) for Automotive Market Outlook, In‑Depth Analysis & Forecast to 2031
Oct 21, 25
Useful links
Our Contacts
Room 2306, T6 Fuxing World Financial Center, Kaifu District, Changsha, Hunan, China
(+86) 159 1069 5232